These data support the general notion that VCP inhibition is a promising strategy to overcome resistance of various cancer types to a broad range of genotoxic chemotherapies but also underscore the need to find reliable predictive biomarkers in order to effectively harness its clinical potential. Here, VCP is linked to cancer.